Back to top

Aardvark Therapeutics Lawsuit Alleges Investors Were Misled Before Major AARD Stock Drops

Aardvark Therapeutics, Inc. (NASDAQ: AARD) is facing a federal securities lawsuit alleging that investors were misled about the safety, tolerabilit...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: